Observational Clinical Trial Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients Participating In Clinical Research
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis
- Sponsor
- Power Life Sciences Inc.
- Enrollment
- 500
- Locations
- 1
- Primary Endpoint
- Patient remains in clinical trial to completion
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Historically, participation in clinical trials has been highly skewed towards specific demographic groups. However, research identifying which trial attributes impact participation, in either positive or negative ways, is limited. This study invites participants to record a wide range of data on their clinical trial experience, with the goal being to identify factors which persistently limit patients' ability to participate in, or complete, a trial in which they were initially interested. This data will be analyzed through a range of demographic lenses, in hopes of discovering patterns which might improve the experience of future rheumatoid arthritis patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient has been diagnosed with rheumatoid arthritis
- •Patient has self-identified as planning to enroll in an interventional clinical trial
- •Patient is 18 years old
Exclusion Criteria
- •ECOG score of 4
- •Patient is pregnant
- •Inability to perform regular electronic reporting
- •Patient does not understand, sign, and return consent form
Outcomes
Primary Outcomes
Patient remains in clinical trial to completion
Time Frame: 12 months
Patient decides to enroll in clinical trial
Time Frame: 3 Months